Inventor · disambiguated record
Liliana Bar
Also filed as: BAR LILIANA
28 granted patents·8 pending applications·234 citations·filing 1999–2024
96Inventor score
Files withOMRIX BIOPHARMACEUTICALS LTD12NUR ISRAEL6OMRIX BIOPHARMACEUTICALS INC3KAMADA LTD2OPPERBAS HOLDING BV2
Top patents by PatentIndex Score
36 records- 0196US7125569B2Removal of plasmin(ogen) from protein solutionsOMRIX BIOPHARMACEUTICALS INC·Filed 2002·Granted Oct 24, 2006·83 cites·8 claims
- 0288US8354249B2Intravenous immunoglobulin compositionOMRIX BIOPHARMACEUTICALS LTD·Filed 2005·Granted Jan 15, 2013·13 cites·20 claims
- 0387US7641918B2Plasma cryoprecipitate substantially free of plasminogenOMRIX BIOPHARMACEUTICALS INC·Filed 2006·Granted Jan 5, 2010·6 cites·4 claims
- 0487US2024376459A1Thrombin solution and methods of use thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 0586US8322637B2Method of micronizationNUR ISRAEL·Filed 2007·Granted Dec 4, 2012·4 cites·17 claims
- 0684US9125906B2Treatment of peripheral vascular disease using umbilical cord tissue-derived cellsBUENSUCESO CHARITO S·Filed 2011·Granted Sep 8, 2015·9 cites·28 claims
- 0783US9585918B2Treatment of peripheral vascular disease using umbilical cord tissue-derived cellsDEPUY SYNTHES PRODUCTS INC·Filed 2015·Granted Mar 7, 2017·2 cites·20 claims
- 0883US6468733B2Method of the inactivation of viruses by a solvent-detergent combination and nanofiltrationOMRIX BIOPHARMACEUTICALS INC·Filed 2001·Granted Oct 22, 2002·42 cites·10 claims
- 0982US9439997B2Reinforced absorbable multilayered hemostatis wound dressingGORMAN ANNE JESSICA·Filed 2006·Granted Sep 13, 2016·4 cites·9 claims
- 1081US9365635B2Intravenous immunoglobulin compositionNUR ISRAEL·Filed 2012·Granted Jun 14, 2016·3 cites·5 claims
- 1181US8475812B2Gelatin sponge comprising an active ingredient, its preparation and useNUR ISRAEL·Filed 2009·Granted Jul 2, 2013·6 cites·15 claims
- 1280US6930087B2Pharmaceutical composition comprising factor VIII and neutral liposomesOPPERBAS HOLDING BV·Filed 2002·Granted Aug 16, 2005·10 cites·17 claims
- 1376US9328338B2Method for removing a lytic enzyme from a heterogeneous mixtureMEIDLER ROBERTO·Filed 2012·Granted May 3, 2016·5 cites·15 claims
- 1474US8563288B2Removal of plasmin or plasminogen from cryoprecipitateNUR ISRAEL·Filed 2008·Granted Oct 22, 2013·2 cites·16 claims
- 1574US6593294B1Pharmaceutical composition comprising Factor VIII and neutral liposomesOPPERBAS HOLDING BV·Filed 1999·Granted Jul 15, 2003·36 cites·17 claims
- 1673US11993797B2Thrombin solution and methods of use thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2021·Granted May 28, 2024·0 cites·12 claims
- 1769US11225652B2Thrombin solution and methods of use thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2019·Granted Jan 18, 2022·0 cites·12 claims
- 1869US9023994B2Immunoglobulin reduced in thrombogenic agents and preparation thereofMINTZ RONI·Filed 2012·Granted May 5, 2015·2 cites·14 claims
- 1969US8981058B2Gelatin sponge comprising an active ingredient, its preparation and useNUR ISRAEL·Filed 2013·Granted Mar 17, 2015·1 cites·7 claims
- 2068US8968724B2Compositions suitable for treatment of spinal disease, disorder or conditionBECHOR EDNA·Filed 2008·Granted Mar 3, 2015·2 cites·11 claims
- 2166US10039865B2Implantable device comprising a substrate pre-coated with stabilized fibrinSHEETRIT EYAL·Filed 2009·Granted Aug 7, 2018·1 cites·9 claims
- 2266US9213035B2Protein assayDE ANGLIS ASHLEY·Filed 2008·Granted Dec 15, 2015·3 cites·25 claims
- 2365US9212357B2Thrombin solution and methods of use thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2013·Granted Dec 15, 2015·0 cites·9 claims
- 2464US10479987B2Thrombin solution and methods of use thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2015·Granted Nov 19, 2019·0 cites·9 claims
- 2560US9896716B2Protein assayOMRIX BIOPHARMACEUTICALS LTD·Filed 2015·Granted Feb 20, 2018·0 cites·3 claims
- 2660US9427490B2Gelatin sponge comprising an active ingredient, its preparation and useOMRIX BIOPHARMACEUTICALS LTD·Filed 2015·Granted Aug 30, 2016·0 cites·4 claims
- 2757US2015196680A1Gelatin sponge comprising an active ingredient, its preparation and useOMRIX BIOPHARMACEUTICALS LTD·Filed 2015·Application pending·0 cites
- 2857US2010203033A1Kits, formulations and solutions having enzymatically- permissive amounts of visualization agents and uses thereofNUR ISRAEL·Filed 2008·Application pending·0 cites
- 2956US2004197891A1Removal of plasmin(ogen) from protein solutionsFiled 2002·Application pending·0 cites
- 3049US2018093010A1Kits, formulations and solutions having enzymatically- permissive amounts of visualization agents and uses thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2017·Application pending·0 cites
- 3147US2021085764A1Dry powder formulations of alpha-1 antitrypsinKAMADA LTD·Filed 2017·Application pending·0 cites
- 3245US9796770B2Immunoglobulin reduced in thrombogenic agents and preparation thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2015·Granted Oct 24, 2017·0 cites·22 claims
- 3344US9326998B2Compositions suitable for treatment of spinal disease, disorder or conditionOMRIX BIOPHARMACEUTICALS LTD·Filed 2015·Granted May 3, 2016·0 cites·4 claims
- 3438US2012039855A1Fibrin based scaffold, preparation and use thereofATLAS ROEE·Filed 2011·Application pending·0 cites
- 3534US10722535B2Compositions derived from Cohn fraction paste and use thereofKAMADA LTD·Filed 2016·Granted Jul 28, 2020·0 cites·10 claims
- 3629US2010217231A1Device for administering an at least two-component substanceILAN EREZ·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Liliana Bar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →